Prospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 7, 2017; 23(21): 3890-3899
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3890
Figure 1
Figure 1 Receiver operating characteristic curve for fecal calprotectin concentration in predicting ulcerative colitis relapse. The area under the curve was 0.78 (95%CI: 0.55-1.0). ROC: Receiver operating characteristic.
Figure 2
Figure 2 Partial least squares discriminant analysis plot showing a clear separation of the metabolomic fingerprints of ulcerative colitis patients in clinical remission who developed a Relapse or stayed in Remission within 12 mo of follow-up (R2 = 0. 84, Q2 = 0.59, P = 0.04).